Table I Index
Table of Contents
|
Table I - 22 Floyd Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 317 | 382.3 | 161 | 462.1 | 156 | 337.8 |
| Oral cavity and pharynx | 9 | 12.0** | 5 | 15.0** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 55 | 63.6 | 30 | 85.7 | 25 | 46.3 |
| Esophagus | * | # | * | # | * | # |
| Stomach | 7 | 8.7** | 5 | 13.7** | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 22 | 24.4 | 7 | 20.4** | 15 | 25.9** |
| Rectum and rectosigmoid | 10 | 12.0** | 5 | 13.6** | 5 | 10.5** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 7 | 7.2** | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 67 | 84.4 | 39 | 113.2 | 28 | 67.0 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 62 | 77.3 | 36 | 104.9 | 26 | 60.7 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 14 | 17.8** | 8 | 23.0** | 6 | 13.3** |
| Melanoma of the skin | 14 | 17.8** | 8 | 23.0** | 6 | 13.3** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 50 | 60.0 | * | # | 50 | 109.5 |
| Female genital system | 16 | 19.0** | -- | -- | 16 | 34.0** |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 7 | 8.7** | -- | -- | 7 | 15.6** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 5 | 5.8** | -- | -- | 5 | 10.5** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 42 | 51.0 | 42 | 122.6 | -- | -- |
| Prostate gland | 39 | 48.1 | 39 | 114.9 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 27 | 32.0 | 17 | 49.6** | 10 | 22.0** |
| Urinary bladder | 16 | 18.1** | 12 | 35.6** | * | # |
| Kidney and renal pelvis | 11 | 13.9** | 5 | 14.0** | 6 | 14.1** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 5 | 5.0** | * | # | * | # |
| Brain | 5 | 5.0** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 13 | 16.0** | 8 | 21.2** | 5 | 12.3** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 12 | 14.9** | 7 | 18.4** | 5 | 12.3** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 6 | 6.2** | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 5 | 5.4** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||